Aeravti Ventures has fully deployed its maiden venture capital fund across seven early-stage startups in sectors including deep-tech and agri-tech. The firm is now preparing to launch a second, larger fund. This move highlights continued interest in specialized technology segments, though investors should note the long-term, illiquid, and high-risk nature of such private venture capital investments.
Aeravti Ventures, a Bengaluru-based, SEBI-registered venture capital firm, has successfully concluded the deployment of its maiden fund. The firm focused on a high-conviction strategy, choosing to cap its fund size rather than maximize the total corpus, which stood at approximately ₹100 crore. This capital has now been invested in seven early-stage companies operating in complex sectors such as deep-tech, agri-tech, climate-tech, and biosciences.
It is important to note that Aeravti Ventures is a private investment firm and not a publicly traded stock on the NSE or BSE. As a result, there is no share price movement or public market ticker associated with this announcement. For individual investors, this news serves as an indicator of trends in private equity funding rather than a direct investment opportunity.
The firm’s investment strategy prioritizes long-term commitment, often acting as a lead investor in funding rounds to maintain significant ownership and work closely with founders. The portfolio includes startups like ONO, Origin Fresh, East Ocyon Bio, and FreightFox. Early validation of this approach is visible in the follow-on funding secured by three of these portfolio companies, which the firm views as a sign of progress in the founders' execution capabilities.
Looking ahead, Aeravti Ventures is actively preparing to launch its second fund, with a reported target corpus between ₹250 crore and ₹300 crore. The firm intends to maintain its focus on building businesses from the ground up, with a long-term investment horizon of 8 to 10 years. While it remains open to exits within 4 to 6 years should liquidity opportunities emerge, the primary goal remains supporting early-stage ventures through their growth phases.
Investors tracking the private venture capital space should understand the specific risks associated with this asset class. Startups in deep-tech and agri-tech often face extended research and development cycles, making them highly dependent on continuous capital infusion before reaching commercial viability. Furthermore, because these are private holdings, capital is highly illiquid. Realizing returns depends entirely on the future success of these companies, such as through an acquisition by a larger entity or an eventual public listing. The success of the second fund will likely depend on the firm's ability to navigate these long-term risks while managing the transition from an early-stage portfolio to mature, exit-ready assets.